The EDN1 gene makes endothelin-1, a signaling protein that helps blood vessels tighten, supports blood pressure control, and guides development of parts of the face and heart. If this gene does not work properly, blood vessel control can change and, in rare inherited conditions, the jaw, outer ears, or heart may develop differently. Many variants are harmless, while a few may change how the gene works. EDN1 is mainly known in medicine rather than popular culture.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or direct activities in the body. Some genes provide the information for making proteins, the parts of cells that do much of the work. Others are used mainly to regulate when certain processes happen, where they happen, and how strongly they occur. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can read more in LearnHub.
Overview
EDN1Gene function
What if the gene works
The EDN1 gene helps make a signaling protein that tightens blood vessels. This helps control blood pressure and blood flow. It also supports normal development of the face and heart before birth.
Risk
What if the gene does not work
Variants in the EDN1 gene can disrupt lower face and ear development, causing auriculocondylar syndrome. Effects can range from subtle jaw or ear differences to more marked changes in facial shape, depending on how strongly the variant alters gene function.
Treatment
What does that mean for your treatment
No EDN1-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the EDN1 gene. The endothelin pathway that includes the EDN1 gene is an active research area, and some drugs block endothelin receptors, but these treatments are not selected based on an EDN1 variant itself.
Conditions associated with EDN1
Gene function
What if the gene works
Healthy circulation depends on tiny, well timed signals that tell blood vessels when to tighten or relax. The EDN1 gene helps make one of these signals, called endothelin-1. When this system is balanced, blood flow and pressure stay better matched to your body's needs.
The EDN1 gene helps blood vessels tighten in a controlled way when your body needs to adjust circulation. This steady control is a central part of how the EDN1 gene affects blood pressure and blood flow.
Cells lining blood vessels release the EDN1 signal to communicate with the muscle layer around them. This helps nearby vessels respond smoothly to changes in activity, temperature, and oxygen demand.
By fine tuning vessel tone, this gene helps send blood where it is most needed, such as muscles during movement or skin in cooler conditions. Proper EDN1 activity supports flexible, day to day circulation.
During early growth, EDN1 signaling helps guide the shaping of parts of the face and jaw. It also supports normal patterning of some blood vessels as tissues form.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the EDN1 gene can change how the protein is processed into its active signaling form and how strongly it can interact with its receptors. This explains how EDN1 gene variants affect cell signaling: some leave partial activity, while more disruptive variants can greatly reduce or block the signal. In conditions linked to the EDN1 gene, that functional range may shape how early developmental changes appear and how marked they become.
How variants are linked to conditions
Pathogenic variants in the EDN1 gene can cause auriculocondylar syndrome type 3, a rare inherited condition that affects how the lower jaw and outer ears develop. People with this condition may have a small or uneven lower jaw, unusual ear shape, and sometimes breathing or feeding difficulties, especially early in life. Variants in the EDN1 gene linked to auriculocondylar syndrome are rare, and this diagnosis is based on the specific variant rather than a common risk marker.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and instead represent natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to EDN1 itself. Personal risk usually depends more on the exact gene change, family history, and the health condition involved, so discussing your results with a doctor or genetic counselor can help put them in context.
Inheritance of EDN1 variants
EDN1-related conditions are most often inherited in an autosomal dominant pattern. This means a person with a disease-causing variant in one copy of the EDN1 gene can pass it to each child, with a 50% chance in every pregnancy. In families learning how EDN1 gene variants are inherited, it also helps to know that some affected people have a new (de novo) variant that was not inherited from either parent. Men and women can inherit and pass on the variant equally.
What does my EDN1 result mean for my family?
For the best-known condition linked to the EDN1 gene, the result is usually inherited in a dominant way, which means close relatives such as parents, brothers, sisters, and children may also carry the same gene change. In families where a parent has the variant, each child has a 1 in 2, or 50%, chance of inheriting it. Some people with an EDN1 change are the first in their family to have it.
Genetic information
Genetic testing
How you find out about variants
EDN1 genetic testing usually uses a blood or saliva sample to look for variants in the EDN1 gene. A lab reads the gene’s DNA code and compares it with the usual sequence, then reports whether a variant was found and whether it is known to help explain a diagnosed or suspected condition.
When should I consider getting a genetic test?
Genetic testing for the EDN1 gene may be worth discussing if a child is born with unusual ear shape, a very small lower jaw, or other facial differences that suggest auriculocondylar syndrome, a rare condition present from birth. It can also help when these features run in a family.
A genetic result is only one part of your health story
Genetic findings can provide useful insight, yet the amount they explain varies with the condition and the kind of variant present. Over time, the way the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, these results can help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in the genes involved in handling drugs can change how the body absorbs, breaks down, or responds to a treatment, so the same medicine may work better for one person than for another. This is common and can influence how much benefit someone gets or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences affect how people respond to medicines. By studying links between genes and medications, it helps explain why the same treatment can work differently in different people. For many drugs, genes can influence either how strongly a medicine works or how the body processes it. This information can support treatment choices that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the EDN1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose, so questions about side effects, treatment response, or your overall health are best discussed with your doctor. EDN1 has been studied in research on blood pressure and blood vessel medicines, but those findings are not used routinely to make treatment decisions.
History
The EDN1 gene entered medical research in 1988, when scientists in Japan identified endothelin as a powerful signal made by blood vessel lining cells. This finding quickly drew attention because it changed how researchers thought about blood vessel control and high blood pressure. From these first observations, research expanded steadily. In the years that followed, the EDN1 gene became part of a broader effort to map the body’s chemical signaling systems and understand conditions affecting the heart, lungs, and circulation. Its discovery is still remembered as an important step in modern vascular biology, helping connect basic laboratory science with everyday health problems seen in clinics.